Blood Tests for Amyloid Step Out at CTAD (Links to an external site)

Blood Tests for Amyloid Step Out at CTAD
It seems blood tests for Aβ have moved off the wish list and are becoming reality—almost. Building a knowledge base for plasma measures as a proxy for brain amyloid, multiple methods applied to different research cohorts are now consistently linking low plasma Aβ42/40 to clinical, cognitive, and biomarker evidence of Alzheimer’s disease.